Study to Create Potential Cell-Based Therapies to Treat Human Disease and Disability
This is a research study in which your cells will be used for somatic cell nuclear transfer (SCNT), and/or genetic reprogramming research which may result in the production of stem cell lines. This study does not provide treatment.
Stanford is currently accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- procedure: Improving the scientific process of human cell reprogramming
Eligibility
Inclusion Criteria:1. Donors with a degenerative disease phenotype or genetic disorders
such as Type I Diabetes, heart disease, or infertility (azoospermia and premature ovarian
failure)
Exclusion Criteria:1. Unable to read or understand English. 2. Unable to provide skin
biopsy sample due to skin condition in the underarm area.
Ages Eligible for Study
1 Year - 75 Years
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Tasha Kalista
6507259977
I'm interested
Our research team includes physicians, residents, medical students, research assistants, and volunteers. Our research topics include medical imaging, device validation, mobile application development, and pharmaceutical trials.
Some of the Neuro-Opthalmic concerns we investigate include Multiple Sclerosis, Optic Neuritis, IIH, and ICP.